Assignee
ALIGOS THERAPEUTICS INC
US·35 granted patents·31 pending applications·46 citations·filing 2019–2025
Top patents by PatentIndex Score
66 records- 0197US11851422B2Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2022·Granted Dec 26, 2023·8 cites·61 claims
- 0297US11091467B2Modulators of THR-β and methods of use thereofALIGOS THERAPEUTICS INC·Filed 2020·Granted Aug 17, 2021·6 cites·17 claims
- 0395US11549110B2Modified short interfering nucleic acid (siNA) molecules and uses thereofALIGOS THERAPEUTICS INC·Filed 2022·Granted Jan 10, 2023·5 cites·30 claims
- 0495US11191747B2Pyrrole compoundsALIGOS THERAPEUTICS INC·Filed 2020·Granted Dec 7, 2021·3 cites·30 claims
- 0595US11136321B2Tricyclic compoundsALIGOS THERAPEUTICS INC·Filed 2020·Granted Oct 5, 2021·4 cites·20 claims
- 0692US12129469B2Modified short interfering nucleic acid (siNA) molecules and uses thereofALIGOS THERAPEUTICS INC·Filed 2023·Granted Oct 29, 2024·1 cites·30 claims
- 0792US12018015B2Methods and compositions for targeting PD-L1ALIGOS THERAPEUTICS INC·Filed 2022·Granted Jun 25, 2024·2 cites·21 claims
- 0892US11952365B2Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2021·Granted Apr 9, 2024·2 cites·18 claims
- 0992US11820773B2Tricyclic compoundsALIGOS THERAPEUTICS INC·Filed 2021·Granted Nov 21, 2023·2 cites·21 claims
- 1090US11771680B2Pyrrole compoundsALIGOS THERAPEUTICS INC·Filed 2021·Granted Oct 3, 2023·1 cites·19 claims
- 1190US11760761B2Methods and compositions for targeting PD-L1ALIGOS THERAPEUTICS INC·Filed 2021·Granted Sep 19, 2023·2 cites·26 claims
- 1289US12065428B2Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2022·Granted Aug 20, 2024·1 cites·23 claims
- 1389US11760764B2Methods and compositions for targeting PD-L1ALIGOS THERAPEUTICS INC·Filed 2021·Granted Sep 19, 2023·2 cites·24 claims
- 1488US11957683B2Bicyclic compoundsALIGOS THERAPEUTICS INC·Filed 2022·Granted Apr 16, 2024·1 cites·46 claims
- 1588US11952374B2Bicyclic compoundsALIGOS THERAPEUTICS INC·Filed 2021·Granted Apr 9, 2024·1 cites·21 claims
- 1685US11166976B2S-antigen transport inhibiting oligonucleotide polymers and methodsALIGOS THERAPEUTICS INC·Filed 2020·Granted Nov 9, 2021·1 cites·6 claims
- 1783US2025304561A1Modulators of thr-beta and methods of use thereofALIGOS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1882US12252481B2Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2023·Granted Mar 18, 2025·0 cites·23 claims
- 1982US11033556B2Bicyclic sulfonamidesALIGOS THERAPEUTICS INC·Filed 2020·Granted Jun 15, 2021·1 cites·27 claims
- 2081US11466274B2Modified gapmer oligonucleotides and methods of useALIGOS THERAPEUTICS INC·Filed 2020·Granted Oct 11, 2022·1 cites·16 claims
- 2181US11198699B2Compounds targeting PRMT5ALIGOS THERAPEUTICS INC·Filed 2020·Granted Dec 14, 2021·1 cites·26 claims
- 2280US2026002157A1MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) MOLECULES AND USES THEREOFALIGOS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2379US11591341B2Bicyclic and tricyclic compoundsALIGOS THERAPEUTICS INC·Filed 2020·Granted Feb 28, 2023·1 cites·30 claims
- 2478US2023332153A1Modified Short Interfering Nucleic Acid (siNA) Molecules and Uses ThereofALIGOS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2577US12534450B2Methods and compositions for targeting PD-L1ALIGOS THERAPEUTICS INC·Filed 2024·Granted Jan 27, 2026·0 cites·19 claims
- 2676US12454691B2Modified short interfering nucleic acid (siNA) molecules and uses thereofALIGOS THERAPEUTICS INC·Filed 2022·Granted Oct 28, 2025·0 cites·29 claims
- 2771US12180192B2Modulators of THR-β and methods of use thereofALIGOS THERAPEUTICS INC·Filed 2021·Granted Dec 31, 2024·0 cites·23 claims
- 2870US2022364096A1Modified Short Interfering Nucleic Acid (siNA) Molecules and Uses ThereofALIGOS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2969US2025243187A1Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3066US2024199647A1Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3166US2024182444A1Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3266US2022125825A1S-antigen transport inhibiting oligonucleotide polymers and methodsALIGOS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3366US2023383296A1Modified gapmer oligomers and methods of use thereofALIGOS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3466US2024352464A1Modified Short Interfering Nucleic Acid (siNA) Molecules and Uses ThereofALIGOS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3565US2024018126A1Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3665US2022048922A1Compounds targeting prmt5ALIGOS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3765US2024150351A1Bicyclic compoundsALIGOS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3864US2023382909A1Bicyclic compoundsALIGOS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3964US2024277706A1Methods and compostitions for targeting pd-l1ALIGOS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4063US12384779B2Bicyclic compoundsALIGOS THERAPEUTICS INC·Filed 2023·Granted Aug 12, 2025·0 cites·18 claims
- 4162US2025206725A1Modulators of thr-beta and methods of use thereofALIGOS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4260US12428427B2Methods and compositions for targeting PD-L1ALIGOS THERAPEUTICS INC·Filed 2022·Granted Sep 30, 2025·0 cites·23 claims
- 4360US11858913B2Bicyclic pyridazinones and methods of use thereofALIGOS THERAPEUTICS INC·Filed 2021·Granted Jan 2, 2024·0 cites·18 claims
- 4459US11840532B2Modulators of THR-β and methods of use thereofALIGOS THERAPEUTICS INC·Filed 2021·Granted Dec 12, 2023·0 cites·12 claims
- 4559US11793815B2Oxindoles and methods of use thereofALIGOS THERAPEUTICS INC·Filed 2021·Granted Oct 24, 2023·0 cites·23 claims
- 4659US11786532B22-pyridones and methods of use thereofALIGOS THERAPEUTICS INC·Filed 2021·Granted Oct 17, 2023·0 cites·19 claims
- 4759US2022160748A1Conjugates of s-antigen transport inhibiting oligonucleotide polymers having enhanced liver targetingALIGOS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4858US2022000874A1Tricyclic compoundsALIGOS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4957US2025382618A1Methods and compositions for inhibiting virusALIGOS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 5057US2025243491A1Pnpla3-targeting short interfering rna (sirna) molecules and uses thereofALIGOS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Showing the top 50 of 66 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →